Laia Malet Sanz

Laia Malet Sanz has worked in various roles in the medicinal chemistry field since 2003. Laia began their career at Pfizer as a Senior Scientist in 2003. In 2009, they took on a Senior Scientist role at the University of Cambridge. In 2012, they began working at Eli Lilly and Company as a Senior Scientist and Medicinal Chemist, and also took on a Chemistry Consultant role at The Research Network. In 2020, they were appointed as Associate Director Medicinal Chemistry and Principal Scientist at OMass Therapeutics.

Laia Malet Sanz has an educational background in Chemistry. Laia obtained a Msci from Queen Mary University of London in 2003, a Licenciatura from Universitat de Barcelona in 2002, and a Bachillerato - High School from IES Sant Mateu High School, Premia de Mar, Barcelona in 1998. Additionally, they have obtained certifications in Artificial Intelligence Foundations: Machine Learning, Intermediate Python, Introduction to Machine Learning with KNIME, Introduction to Python, Creating Great First Impressions, Data Science Foundations: Fundamentals, and CChem - Charted Chemist from various institutions such as LinkedIn and the Royal Society of Chemistry.